Supplementary data1 from First-in-Human Phase I/II Study of INCAGN01876, a Glucocorticoid-Induced Tumor Necrosis Factor Receptor Agonist, in Patients with Advanced or Metastatic Solid Tumors

Authors

Publication Details

Published
2025-10-01
DOI
https://doi.org/10.1158/1078-0432.30255713
Primary Topic
Neuroblastoma Research and Treatments
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Supplementary data1 from First-in-Human Phase I/II Study of INCAGN01876, a Glucocorticoid-Induced Tumor Necrosis Factor Receptor Agonist, in Patients with Advanced or Metastatic Solid Tumors

Taha Merghoub, Xuejun Chen, Dana B. Cardin, Rachana Maniyar et al.
Neuroblastoma Research and Treatments
article

Supplementary data1 from First-in-Human Phase I/II Study of INCAGN01876, a Glucocorticoid-Induced Tumor Necrosis Factor Receptor Agonist, in Patients with Advanced or Metastatic Solid Tumors

Taha Merghoub, Xuejun Chen, Dana B. Cardin, Rachana Maniyar, Omid Hamid, Patricia LoRusso, James J. Harding, Roberta Zappasodi, Zhiwan Dong, F. Stephen Hodi, Feng Zhou, Manfred Velden, John E. Janik
article en

Abstract

No abstract available for this paper.
Openalex Percentile: Top 61%
Neuroblastoma Research and Treatments
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.